- Home
- VIRT vs TVTX Comparison
VIRT vs TVTX Comparison
Compare VIRT & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIRT | TVTX |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | VIRT | TVTX |
|---|---|---|
| Price | $33.45 | $36.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $41.43 | $37.21 |
| AVG Volume (30 Days) | 906.6K | ★ 1.6M |
| Earning Date | 01-28-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ 132.69 | N/A |
| EPS | ★ 4.62 | N/A |
| Revenue | ★ $2,694,104,000.00 | $435,826,000.00 |
| Revenue This Year | N/A | $120.36 |
| Revenue Next Year | N/A | $37.33 |
| P/E Ratio | $7.33 | ★ N/A |
| Revenue Growth | 41.05 | ★ 114.22 |
| 52 Week Low | $31.89 | $12.91 |
| 52 Week High | $45.77 | $37.50 |
Technical Indicators
Market Signals| Indicator | VIRT | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 60.79 |
| Support Level | $33.30 | $33.49 |
| Resistance Level | $34.52 | $36.17 |
| Average True Range (ATR) | 0.84 | 1.55 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 13.31 | 88.27 |
Price Performance
Historical ComparisonAbout VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.